Episode 1 - COVID-19 | Emory School of Medicine

Episode 1 | Aired September 09, 2020
Run time: 27:46

We look at ways the COVID-19 pandemic has impacted our brains and minds – the potential short- and long-term neurological effects of the virus, as well as its impact on society and our families.

Episode Segments

The Kleffner Family

Episode 1 | Segment 1 | Aired September 09, 2020
Run time: 8:51

We follow a family of six who has been sheltering in place, addressing the impact of COVID on children and working parents.

Importance of Positive Psychology

Episode 1 | Segment 2 | Aired September 09, 2020
Run time: 2:54

A third of Americans are showing signs of clinical anxiety or depression during the pandemic – watch how positive psychology can be helpful in combatting this.

COVID-19 Mental Health Guide

Episode 1 | Segment 3 | Aired September 09, 2020
Run time: 3:54

Using its evidence-based model of treatment for veterans, the Emory Healthcare Veterans Program partnered with New York University to create a COVID-19 mental health guide.

James Curran Discusses COVID 19

Episode 1 | Segment 4 | Aired September 09, 2020
Run time: 2:15

Dr. James Curran, Dean of Emory’s Rollins School of Public Health, discusses COVID-19 as a global pandemic and its similarities to the early days of the AIDS crisis.

COVID 19 and Neurological Implications

Episode 1 | Segment 5 | Aired September 09, 2020
Run time: 1:53

This segment features neurological effects from COVID-19 from those who have suffered serious brain injuries from the virus to blood-clotting disorders that cause stroke.

COVID 19 and Increased Substance Use

Episode 1 | Segment 6 | Aired September 09, 2020
Run time: 3:54

This segment explores increased substance abuse during the COVID-19 pandemic and its risk factors like stress, anxiety, depression and housing and financial stability.

Creating a COVID-19 Vaccine

Episode 1 | Segment 7 | Aired September 09, 2020
Run time: 3:36

In a race against COVID-19, Emory researchers are creating a vaccine, taking what they know from HIV-related vaccine efforts and translating it into a potential vaccine.